At PredictCan Biotechnologies we utilize patients’ clinical and pathological data to reprogram cells in a 3D system offering a unique perspective for clinical trial in the dish and personalized therapy.
At PredictCan Biotechnologies we combine cell reprogramming technology with artificial intelligence to detect precancerous signals for early diagnosis and metastasis.
